Women who have rebound weight gain after stopping Wegovy or similar jabs end up gaining more weight during pregnancy, leading ...

FAT jabs could harm mum and baby if taken too close to pregnancy, a study suggests. Women who used the GLP-1 injections, such ...

The pharma giant said amycretin led to weight loss and diabetes reductions in both injection and pill versions.

Four in five people put the weight back on after coming of weight loss jabs, new research has suggested today-and they're not ...

Instead of struggling with weekly injections, patients may soon be able to swallow a daily pill to lose weight. Both the ...

Novo Nordisk's closely watched Alzheimer's trials of an older oral version of its semaglutide drug failed to help slow the ...

The studies were a significant setback for the optimistic view that semaglutide and other GLP-1 drugs could help prevent a ...

Weight loss drugs like Ozempic and Wegovy can be used for a variety of other conditions, such as Alzheimer's, alcohol ...

An older oral version of the company's semaglutide drug failed to meet its main goal in late-stage trials testing whether the ...

The surge in usage of 'GLP-1'-style weight loss medications is seeing a "ripple effect" begin to unfold, impacting eating patterns in a number of ...

The oral version of Rybelsus failed to meet its primary goal in two late-stage clinical trials, which aimed to evaluate its ...

Lilly's $1T valuation and soaring GLP-1 demand spotlight ETFs like IHE, PPH, MEDI, OZEM, MEDX and THNR for investors riding ...